Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bacteria

ABSTRACT: Benchmarking laboratory processes to characterise low-biomass respiratory microbiota

PROVIDER: PRJNA718293 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14149400_1.fastq.gz	Fastqsanger.gz
	SRR14149400_2.fastq.gz	Fastqsanger.gz
	SRR14149500_1.fastq.gz	Fastqsanger.gz
	SRR14149500_2.fastq.gz	Fastqsanger.gz
	SRR14149600_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 2396

Similar Datasets

Bacteria

Project description:Respiratory microbiota in children with severe lower respiratory tract infections.

| PRJNA669463 | ENA

Bacteria

Project description:Upper respiratory tract microbiota Targeted loci

| PRJNA637833 | ENA

Bacteria

Project description:Maturation of respiratory microbiota and risk of respiratory infections in infants: a prospective cohort study

| PRJNA353336 | ENA

RiboReport - Benchmarking ribosome profiling based identification of open reading frames in bacteria.

Project description:Generation of a Ribo-seq dataset for E. coli MG1655 for benchmarking Ribo-seq analysis tools

2022-05-20 | GSE131514 | GEO

Characterisation of the Microbiota of Sputum Samples Derived from Cystic Fibrosis Patients at Different Centres

Project description:The aim of this study is to characterise and compare the composition of the microbiota from sputum samples of cystic fibrosis sufferers from different centres. These data are part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2014-09-16 | E-ERAD-265 | biostudies-arrayexpress

Bacteria

Project description:Shared Hospital Laboratory Bacterial Pathogenomics

| PRJNA964711 | ENA

Dynamic metabolic efficiency of substrate utilization by copiotrophic marine bacteria

Project description:Under well-defined laboratory conditions, we grew R. pomeroyi DSS-3 and A. macleodii MIT1002 in batch cultures on a monosaccharide (glucose) and organic acid (acetate), provided either individually or in combination, and all at the same carbon equivalent. This batch culturing approach mimicked bacterial DOC assimilation in short-lived substrate ‘hot spots’, such as those formed by high phytoplankton extracellular release at peak photon availability. Measurements were made of bacterial metabolite uptake, respiration, and biomass accumulation through a growth cycle. Insights into bacterial core metabolism came from gene and protein expression measured at intervals during growth. Curated genome-scale models (flux balance analysis; FBA) were used to explore the metabolic foundation of CO2 production for insights into determinants of BGE and bCUE.

2023-10-27 | PXD045824 | Pride

Bacteria

Project description:Human lower respiratory tact microbiome

| PRJNA1058613 | ENA

Project description:Low biomass hot springs

| PRJNA533974 | ENA

Metaproteomic analysis of gut microbiota from 30 samples of cystic fibrosis infants

Project description:The link between human gut microbiota (a complex group of microorganisms including not only bacteria but also fungi, viruses, etc.,) and the physiological state is nowadays unquestionable. Metaproteomic has emerged as a useful technique to characterize this microbial community, not just taxonomically, but also focusing on specific biological processes carried out by gut microbiota that may have an effect in the host health or pathological state. Cystic fibrosis is a genetic disease in which the microbiota of the respiratory tract determines the patient's survival and differences in composition of gut microbiota of cystic fibrosis patients respect to healthy infants have been reported. In order to characterize this host-microbiota inter-relation, we carried out the metaproteomic study of 30 stool samples from infants with cystic fibrosis.

2022-10-11 | PXD029284 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data